Floatz logo

Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer

Burkitt Lymphoma

National Cancer Institute (NCI)monoclonal_antibodyPhase 2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

71 Active assets in the Burkitt Lymphoma cohort.

Asset / SponsorPhaseRating
Nivestim
Fred Hutchinson Cancer Center
Phase 4BBB
Vincristine Sulfate
AIDS Malignancy Consortium
Phase 2BBB
Vindesine
PETHEMA Foundation
Phase 4BBB
Cyclosporin A
Fred Hutchinson Cancer Center
Phase 2BBB
Cyclophosphamide
AIDS Malignancy Consortium
Phase 4BBB

View all 50 →

Same molecule, other indications

Immunoglobulin G1, Anti-(Human Cd Antigen Cd27) (Human Monoclonal Cdx-1127 Clone 1F5 Heavy Chain), Disulfide With Human Monoclonal Cdx-1127 Clone 1F5 .Kappa.-Chain, Dimer is also rated in:

B-cell non-Hodgkin lymphomaActive
CCC
Indicative · Phase 2
51 / 100
View asset →
melanomaDormant
CCC
Indicative · Phase 2
49 / 100
View asset →
glioblastomaActive
CC
Indicative · Phase 2
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →